## DD: DuPont de Nemours, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 0.9% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($39.41)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Mizuho Forecasts Strong Price Appreciation for DuPont de Nemours (NYSE:DD) Stock**
- Source: MarketBeat | 20251218T135427 | Bullish | Relevance: 100%
- Mizuho has raised its target price for DuPont de Nemours (NYSE:DD) to $46 from $44, maintaining an "outperform" rating and implying a 13.2% upside. Despite some recent target trims from other firms, the consensus remains a "Moderate Buy" with an average target of $43.69. Additionally, DuPont's board authorized a $2.0 billion share repurchase program, signaling management's belief that the stock may be undervalued.

**2. Jim Cramer Says "Do Not Sell DuPont (DD)"**
- Source: Finviz | 20251218T001018 | Bullish | Relevance: 100%
- Jim Cramer advises against selling DuPont (DD) despite the Qnity Electronics spinoff and an upcoming dividend reduction, citing the strong leadership of Lori Koch and the excellent performance of its water and materials businesses. He believes in the company's story, particularly the value proposition of the Qnity spinoff and the potential for Executive Chairman Ed Breen to unlock further value, even while acknowledging challenges without rate cuts. Cramer's Charitable Trust also holds DuPont stock.

**3. CHEMOURS: President of titanium dioxide unit departs / Successor to take over in early 2026**
- Source: Plasteurope.com | 20251219T131016 | Neutral | Relevance: 100%
- DamiÃ¡n Gumpel, head of Chemours' titanium dioxide business, is leaving the company after only starting at the beginning of the year. Michael Foley is slated to take over the role in February 2026, with CEO Denise Dignam heading the division in the interim. This departure follows a difficult year for Chemours, marked by underperforming titanium dioxide business and significant PFAS-related compensation payments.

**4. Mizuho Securities Adjusts DuPont de Nemours Price Target to $46 From $44, Maintains Outperform Rating**
- Source: marketscreener.com | 20251218T145244 | Somewhat-Bullish | Relevance: 100%
- Mizuho Securities has revised its price target for DuPont de Nemours (DD) to $46, an increase from the previous $44. The firm has simultaneously reiterated its "Outperform" rating for the specialty chemicals company. This update reflects Mizuho's continued positive outlook on DuPont de Nemours' stock performance.

**5. 24 DuPont de Nemours (NYSE:DD) Shares Little Changed in Trade Session**
- Source: Kalkine Media | 20251218T143044 | Neutral | Relevance: 100%
- DuPont de Nemours (NYSE:DD) shares experienced little change during a recent trade session, with the company operating in the basic materials sector. The article provides a detailed look at DuPont de Nemours' segment organization, global operations, and research integration. It also briefly covers why the company is associated with broad market index groupings.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Mizuho | $46 | $44 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Mizuho | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 11 ($0.27M) |
| Sells | 2 ($0.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+6.7%)
- Blackrock Inc.: 7.6% (-5.1%)
- State Street Corpora: 4.3% (-0.9%)
- Geode Capital Manage: 2.6% (+1.5%)
- Nuveen, LLC: 2.1% (+7.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.78 indicates undervaluation relative to growth. Forward P/E 19.1x attractive for 25% earnings growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.3B |
| Beta | 1.14 |
| 52W Range | $22.50 - $41.83 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.78 |
| Forward P/E | 19.1 |
| Current P/E | 23.9 |
| YoY Growth | 25.5% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 2.1% to 0.9% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.1pp (needs >3.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.90% (CS: 70) | Neutral |
| RSI_14 | 65.4 | Neutral |
| MACD Histogram | -0.11 | Bearish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.096x | Above |
| vs SMA200 | 1.292x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $41.23
- **Stop Loss:** $39.41 (4.4% risk)
- **Target:** $43.05 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 494
- **Position Value:** $20,367.62
- **Portfolio %:** 20.37%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-10 (Est: $0.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.98 | $1.09 | +11.2% |
| 2025Q2 | $1.06 | $1.12 | +5.5% |
| 2025Q1 | $0.95 | $1.03 | +8.1% |
| 2024Q4 | $0.98 | $1.13 | +15.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*